Nonstructural protein 5A/P32 deletion after failure of ledipasvir/sofosbuvir in hepatitis C virus genotype 1b infection

Hepatology. 2018 Jul;68(1):380-383. doi: 10.1002/hep.29836. Epub 2018 May 14.
No abstract available

Publication types

  • Case Reports
  • Research Support, Non-U.S. Gov't

MeSH terms

  • Aged
  • Antiviral Agents / therapeutic use
  • Benzimidazoles / therapeutic use
  • Fluorenes / therapeutic use
  • Genotype
  • Hepacivirus / genetics*
  • Hepatitis C / drug therapy
  • Hepatitis C / virology*
  • Humans
  • Male
  • Sequence Deletion
  • Sofosbuvir / therapeutic use
  • Treatment Failure
  • Viral Nonstructural Proteins / genetics*

Substances

  • Antiviral Agents
  • Benzimidazoles
  • Fluorenes
  • Viral Nonstructural Proteins
  • ledipasvir
  • NS-5 protein, hepatitis C virus
  • Sofosbuvir